Community Health Systems, Inc. (CYH) AI Stock Analysis

NYSE: CYHAI research summary: business, growth, valuation, analysts, bull and bear case.

CYH AI stock analysis summary

AI Research

Community Health Systems, Inc. (CYH) is a US hospital and healthcare facility operator with a market cap of $406.1M. Over the trailing twelve months, the company generated $11.98B in revenue with an operating margin of 7.7%, but faces high leverage with $10.21B in total debt and negative equity of -$1.39B.

Market cap
$406.1M
Revenue (TTM)
$11.98B
P/E
1.6x
fwd 17.6x
1Y return
-5.9%
S&P 500 16.8%
Avg. target
$3.09
7.4% vs last close

Bull case

  • The company posted positive free cash flow of $208.0M and operating cash flow of $543.0M in FY2025.
  • CYH's EV/EBITDA multiple of 6.0x represents a discount relative to the US-listed Healthcare peer median of 12.0x.
  • The consensus analyst price target of $3.09 reflects a 7.4% premium over the last close of $2.88.

Bear case

  • The balance sheet carries substantial leverage, with $10.21B in debt against $149.0M in cash and short-term investments as of June 30, 2026.
  • Shareholders' equity stands at -$1.39B, reflecting an ongoing negative equity position.
  • In the latest quarter ended June 30, 2026, quarterly earnings fell 75.6% year-over-year alongside a 9.8% decline in revenue.

What Community Health Systems does

Community Health Systems, Inc. operates a network of general acute care hospitals across the United States through ownership and lease agreements. Established in 1985 and based in Franklin, Tennessee, the company provides inpatient medical services including general acute care, emergency room services, specialty surgeries, critical care, obstetrics, psychiatric care, and rehabilitation. In addition, it operates outpatient facilities such as primary care practices, urgent care centers, ambulatory surgery centers, free-standing emergency departments, diagnostic imaging centers, retail clinics, and virtual health visits. As of December 31, 2021, the company operated 83 hospitals totaling approximately 13,289 licensed beds.

Growth and profitability

Between FY2021 and FY2025, revenue stayed within a narrow range, moving from $12.37B in FY2021 to $12.48B in FY2025, representing a 5-year revenue CAGR of 1.2%. Gross margin declined significantly from 41.1% in FY2021 to 8.7% in FY2025, while FY2025 operating margin stood at -79.4%. Net income was volatile over this period, shifting from -$516.0M in FY2024 to $509.0M in FY2025, yielding an EPS of $1.99. In the latest quarter ended June 30, 2026, quarterly revenue fell 9.8% year-over-year, and quarterly earnings decreased 75.6% year-over-year.

CYH income statement →

Balance sheet and cash flow

As of June 30, 2026, Community Health Systems held $149.0M in cash and short-term investments alongside $10.21B in total debt, resulting in net debt of $10.06B. Shareholders' equity remained negative at -$1.39B, with total assets of $12.18B and a current ratio of 1.53. In FY2025, the company generated $543.0M in operating cash flow and $208.0M in free cash flow. Cash deployment in FY2025 included $335.0M in capital expenditures and $2.0M allocated toward share buybacks.

CYH balance sheet →

Valuation and performance

At a last close of $2.88, Community Health Systems trades at a trailing P/E of 1.6x, compared to the median of 24.6x for its US-listed Healthcare peers. Its forward P/E of 17.6x compares to the peer median of 17.3x, while its EV/EBITDA of 6.0x sits below the peer median of 12.0x. Over the past 1-year period, the stock fell 5.9%, trailing the S&P 500 (SPY) gain of 16.8%. Over 5 years, the stock returned -72.2% against an 83.0% return for the benchmark index.

CYH key metrics →

What analysts expect

Wall Street coverage includes 1 Strong Buy, 1 Buy, 5 Hold, 2 Sell, and 1 Strong Sell rating. The mean price target is $3.09, which is 7.4% above the last close of $2.88. For the current fiscal year ending December 31, 2026, analysts expect revenue of $11.45B and an EPS estimate of -$1.17. For the next fiscal year, 7 analysts project revenue of $11.53B and an EPS of -$0.52. The company beat EPS estimates in 2 of the last 4 quarters, and its next earnings date is October 28, 2026.

CYH forecast and price target →

Key risks and what to watch

  • Total debt of $10.21B results in high interest and refinancing exposure relative to cash holdings of $149.0M.
  • The company has an elevated beta of 1.89, indicating substantial price volatility relative to the broader market.
  • Consensus forecasts call for continued losses, with current fiscal year EPS estimated at -$1.17 and next fiscal year EPS estimated at -$0.52.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this CYH AI stock analysis

This page is an AI-written research summary of Community Health Systems, Inc. (CYH). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: CYH income statement, CYH balance sheet, CYH key metrics, CYH analyst forecast, CYH chart. See the CYH stock overview for the latest quote and news.

CYH AI stock analysis FAQ

Does Community Health Systems pay a dividend?

No, Community Health Systems does not currently pay a dividend.

What is CYH's debt load?

As of June 30, 2026, the company held $10.21B in total debt and $149.0M in cash and short-term investments, resulting in net debt of $10.06B.

What are analysts forecasting for CYH's earnings?

Analysts expect an EPS of -$1.17 on revenue of $11.45B for the fiscal year ending December 31, 2026, followed by an EPS of -$0.52 on revenue of $11.53B in the next fiscal year.

When does Community Health Systems report earnings?

The company's next earnings date is scheduled for October 28, 2026.

More Healthcare AI stock analysis